Atnaujinkite slapukų nuostatas

El. knyga: Harrison's Hematology and Oncology, 3E

4.26/5 (19 ratings by Goodreads)
  • Formatas: PDF+DRM
  • Išleidimo metai: 22-Sep-2016
  • Leidėjas: McGraw-Hill Education
  • Kalba: eng
  • ISBN-13: 9781259835827
Kitos knygos pagal šią temą:
  • Formatas: PDF+DRM
  • Išleidimo metai: 22-Sep-2016
  • Leidėjas: McGraw-Hill Education
  • Kalba: eng
  • ISBN-13: 9781259835827
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Hematology and Oncology – backed by the unmatched authority ofHarrison’s

Featuring a superb compilation of chapters related to hematology and oncology that appear inHarrison’s  Principles of Internal Medicine, Nineteenth Edition (including content from the acclaimedHarrison’s DVD, now appearing in print), this concise, full-color clinical companion delivers the latest knowledge in the field backed by the scientific rigor and authority that have definedHarrison’s. Readers will find content from renowned editors and contributors in a carry-anywhere presentation that is ideal for the classroom, clinic, ward, or exam/certification preparation.

·       Each chapter contains relevant information on the genetics, cell biology, pathophysiology, and treatment of specific disease entities

·       Chapters on hematopoiesis, cancer cell biology, and cancer prevention reflect the rapidly growing body of knowledge in these areas

·       Integration of pathophysiology with clinical management

·       High-yield board review questions make this text ideal for keeping current and preparing for the boards

·       Content updates, new developments and references since the publication ofHarrison’s Principles of Internal Medicine, 19e

·       Helpful appendix of laboratory values of clinical importance

Contributors viii
Preface xi
SECTION I THE CELLULAR BASIS OF HEMATOPOIESIS
1 Hematopoietic Stem Cells
2(8)
David T. Scadden
Dan L. Longo
SECTION II CARDINAL MANIFESTATIONS OF HEMATOLOGIC DISEASE
2 Anemia and Polycythemia
10(12)
John W. Adamson
Dan L. Longo
3 Bleeding and Thrombosis
22(10)
Barbara A. Konkle
4 Enlargement of Lymph Nodes and Spleen
32(9)
Patrick H. Henry
Dan L. Longo
5 Disorders of Granulocytes and Monocytes
41(16)
Steven M. Holland
John I. Gallin
6 Atlas of Hematology and Analysis of Peripheral Blood Smears
57(15)
Dan L. Longo
SECTION III ANEMIAS
7 Iron Deficiency and Other Hypoproliferative Anemias
72(10)
John W. Adamson
8 Disorders of Hemoglobin
82(14)
Edward J. Benz, Jr.
9 Megaloblastic Anemias
96(15)
A. Victor Hoffbrand
10 Hemolytic Anemias and Anemia Due to Acute Blood Loss
111(20)
Lucio Luzzatto
11 Bone Marrow Failure Syndromes Including Aplastic Anemia and Myelodysplasia
131(15)
Neal S. Young
12 Transfusion Biology and Therapy
146(12)
Jeffery S. Dzieczkowski
Kenneth C. Anderson
SECTION IV MYELOPROLIFERATIVE DISORDERS
13 Polycythemia Vera and Other Myeloproliferative Neoplasms
158(10)
Jerry L. Spivak
SECTION V HEMATOLOGIC MALIGNANCIES
14 Acute Myeloid Leukemia
168(13)
Guido Marcucci
Clara D. Bloomfield
15 Chronic Myeloid Leukemia
181(12)
Hagop Kantarjian
Jorge Cortes
16 Malignancies of Lymphoid Cells
193(23)
Dan L. Longo
17 Less Common Hematologic Malignancies
216(15)
Ayalew Tefferi
Dan L. Longo
18 Plasma Cell Disorders
231(14)
Nikhil C. Munshi
Dan L. Longo
Kenneth C. Anderson
19 Amyloidosis
245(9)
David C. Seldin
John L. Berk
SECTION VI DISORDERS OF HEMOSTASIS
20 Disorders of Platelets and Vessel Wall
254(11)
Barbara A. Konkle
21 Coagulation Disorders
265(13)
Valder R. Arruda
Katherine A. High
22 Arterial and Venous Thrombosis
278(7)
Jane E. Freedman
Joseph Loscalzo
23 Deep Venous Thrombosis and Pulmonary Thromboembolism
285(9)
Samuel Z. Goldhaber
24 Antiplatelet, Anticoagulant, and Fibrinolytic Drugs
294(26)
Jeffrey I. Weitz
SECTION VII BIOLOGY OF CANCER
25 Cancer Genetics
320(13)
Pat J. Morin
Jeffrey M. Trent
Francis S. Collins
Bert Vogelstein
26 Cancer Cell Biology
333(27)
Jeffrey W. Clark
Dan L. Longo
SECTION VIII PRINCIPLES OF CANCER PREVENTION AND TREATMENT
27 Approach to the Patient with Cancer
360(13)
Dan L. Longo
28 Prevention and Early Detection of Cancer
373(13)
Jennifer M. Croswell
Otis W. Brawley
Barnett S. Kramer
29 Principles of Cancer Treatment
386(36)
Edward A. Sausville
Dan L. Longo
30 Infections in Patients with Cancer
422(14)
Robert W. Finberg
31 Hematopoietic Cell Transplantation
436(10)
Frederick R. Appelbaum
32 Neoplasia During Pregnancy
446(8)
Michael F. Greene
Dan L. Longo
33 Palliative and End-of-Life Care
454(26)
Ezekiel J. Emanuel
SECTION IX NEOPLASTIC DISORDERS
34 Cancer of the Skin
480(14)
Walter J. Urba
Brendan D. Curti
35 Head and Neck Cancer
494(6)
Everett E. Vokes
36 Neoplasms of the Lung
500(26)
Leora Horn
Christine M. Lovly
David H. Johnson
37 Thymoma
526(3)
Dan L. Longo
38 Breast Cancer
529(13)
Marc E. Lippman
39 Upper Gastrointestinal Tract Cancers
542(9)
Robert J. Mayer
40 Lower Gastrointestinal Cancers
551(10)
Robert J. Mayer
41 Tumors of the Liver and Biliary Tree
561(15)
Brian I. Carr
42 Pancreatic Cancer
576(6)
Elizabeth Smyth
David Cunningham
43 Bladder and Renal Cell Carcinomas
582(7)
Howard I. Scher
Jonathan E. Rosenberg
Robert J. Motzer
44 Benign and Malignant Diseases of the Prostate
589(12)
Howard I. Scher
James A. Eastham
45 Testicular Cancer
601(6)
Robert J. Motzer
Darren R. Feldman
George J. Bosl
46 Gynecologic Malignancies
607(9)
Michael V. Seiden
47 Soft Tissue and Bone Sarcomas and Bone Metastases
616(7)
Shreyaskumar R. Patel
Robert S. Benjamin
48 Primary and Metastatic Tumors of the Nervous System
623(15)
Lisa M. DeAngelis
Patrick Y. Wen
49 Carcinoma of Unknown Primary
638(8)
Gauri R. Varadhachary
James L. Abbruzzese
SECTION X ENDOCRINE NEOPLASIA
50 Thyroid Cancer
646(11)
J. Larry Jameson
Susan J. Mandel
Anthony P. Weetman
51 Endocrine Tumors of the Gastrointestinal Tract and Pancreas
657(28)
Robert T. Jensen
52 Multiple Endocrine Neoplasia
685(15)
Rajesh V. Thakker
53 Pheochromocytoma and Adrenocortical Carcinoma
700(12)
Hartmut P. H. Neumann
SECTION XI REMOTE EFFECTS OF CANCER
54 Paraneoplastic Syndromes: Endocrinologic/Hematologic
712(9)
J. Larry Jameson
Dan L. Longo
55 Paraneoplastic Neurologic Syndromes and Autoimmune Encephalitis
721(11)
Josep Dalmau
Myrna R. Rosenfeld
SECTION XII ONCOLOGIC EMERGENCIES AND LATE EFFECTS AND COMPLICATIONS OF CANCER AND ITS TREATMENT
56 Oncologic Emergencies
732(18)
Rasim Gucalp
Janice P. Dutcher
57 Late Consequences of Cancer and Its Treatment
750(43)
Carl E. Freter
Dan L. Longo
Review and Self-Assessment
757(36)
Charles M. Wiener
Cynthia D. Brown
Brian Houston
Index 793
Dan L. Longo, MDScientific DirectorNational Institute on AgingNational Institutes of HealthBethesda, Maryland